MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

(2016) Daniel J Klionsky et al.   Autophagy

AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment

(2016) N. A. Daurio et al.   CANCER RESEARCH

Identification of AMP-activated protein kinase targets by a consensus sequence search of the proteome

(2015) Traci L Marin et al.   BMC Systems Biology

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage

(2015) Dennis Jine-Yuan Hsieh et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

(2015) Rinath Jeselsohn et al.   Nature Reviews Clinical Oncology

Tamoxifen resistance: From cell culture experiments towards novel biomarkers

(2015) Norbert Nass et al.   PATHOLOGY RESEARCH AND PRACTICE

Properties and clinical relevance of MTA1 protein in human cancer

(2014) Yasushi Toh et al.   CANCER AND METASTASIS REVIEWS

Role of MTA1 in cancer progression and metastasis

(2014) Nirmalya Sen et al.   CANCER AND METASTASIS REVIEWS

Differential Regulation of Estrogen Receptor   Expression in Breast Cancer Cells by Metastasis-Associated Protein 1

(2014) H.-J. Kang et al.   CANCER RESEARCH

Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer

(2014) K. L. Cook et al.   CLINICAL CANCER RESEARCH

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy

(2014) Anika Nagelkerke et al.   ENDOCRINE-RELATED CANCER

Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death

(2014) Katherine L. Cook et al.   FASEB JOURNAL

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

(2014) S Thrane et al.   ONCOGENE

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

(2014) D Elias et al.   ONCOGENE

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells

(2014) J Cui et al.   ONCOGENE

An update on the medical management of breast cancer

(2014) B. Yeo et al.   BMJ-British Medical Journal

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

(2013) Wieslawa H. Dragowska et al.   PLoS One

Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast

(2012) Chun-Wen Cheng et al.   ANNALS OF SURGICAL ONCOLOGY

Glucose-Regulated Protein 78 Controls Cross-talk between Apoptosis and Autophagy to Determine Antiestrogen Responsiveness

(2012) K. L. Cook et al.   CANCER RESEARCH

Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death

(2012) N. Gammoh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

(2011) P N Munster et al.   BRITISH JOURNAL OF CANCER

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: A Randomized Phase II Study

(2011) C. K. Osborne et al.   CLINICAL CANCER RESEARCH

Integrative genomics viewer

(2011) James T Robinson et al.   NATURE BIOTECHNOLOGY

ToppGene Suite for gene list enrichment analysis and candidate gene prioritization

(2009) J. Chen et al.   NUCLEIC ACIDS RESEARCH

Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization

(2008) M. A. Qadir et al.   BREAST CANCER RESEARCH AND TREATMENT

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

(2008) Yi Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer

(2008) M. Chanrion et al.   CLINICAL CANCER RESEARCH

A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance

(2008) J. S. Samaddar et al.   MOLECULAR CANCER THERAPEUTICS

Model-based Analysis of ChIP-Seq (MACS)

(2008) Yong Zhang et al.   GENOME BIOLOGY